Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response. 1987

O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
Vaccine Department, State Serum Institute, Copenhagen, Denmark.

In 24 military recruits vaccinated against tetanus 17-20 years earlier antibody responses were studied 4, 11, and 24 days after revaccination. Antitoxin concentration in serum showed a sigmoid increase with titres at day 4 only just above protective level, corresponding to a risk of susceptibility to be expected even 4 days after revaccination (2.0%, 95% confidence limit). Only after 7 days the risk of unprotection was less than 1%. As the incubation period of tetanus can be as short as 24 hours, revaccination only may not be regarded sufficient if more than 17-20 years have elapsed since primary vaccination and conditions favoring rapid development of tetanus are present. The findings may explain some of the cases of tetanus which have occurred in spite of primary vaccination supplemented by emergency booster. The statement that prophylactic tetanus immunoglobulin is never indicated to persons completely vaccinated earlier should be considered for revision.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
April 1985, Ugeskrift for laeger,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
December 1984, Lancet (London, England),
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
January 1991, Medicinski pregled,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
February 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
January 1984, Annales de recherches veterinaires. Annals of veterinary research,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
November 1981, American journal of veterinary research,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
December 1969, The Journal of hygiene,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
October 1969, American journal of epidemiology,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
January 2015, Human vaccines & immunotherapeutics,
O Simonsen, and M Klaerke, and J E Jensen, and K Kjeldsen, and C Hau, and I Heron
October 1962, American journal of public health and the nation's health,
Copied contents to your clipboard!